Lexicon Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2009 | $-89.0M | $-89.4M | $369.0K | $5.3M |
| FY2010 | $-82.4M | $-83.5M | $1.1M | $5.5M |
| FY2011 | $-87.9M | $-89.1M | $1.2M | $5.7M |
| FY2012 | $-94.5M | $-95.0M | $492.0K | $6.5M |
| FY2013 | $-91.1M | $-92.8M | $1.7M | $7.4M |
| FY2014 | $-75.6M | $-75.7M | $80.0K | $7.1M |
| FY2015 | $184.8M | $183.9M | $910.0K | $6.8M |
| FY2016 | $-175.6M | $-175.9M | $231.0K | $7.5M |
| FY2017 | $-185.4M | $-185.6M | $228.0K | $9.5M |
| FY2018 | $-148.6M | $-148.7M | $95.0K | $11.7M |
| FY2019 | $113.8M | $113.7M | $70.0K | $14.2M |
| FY2020 | $-143.0M | $-143.1M | $87.0K | $13.3M |
| FY2021 | $-87.0M | $-88.2M | $1.2M | $10.6M |
| FY2022 | $-88.9M | $-90.2M | $1.3M | $11.5M |
| FY2023 | $-161.9M | $-162.4M | $470.0K | $14.3M |
| FY2024 | $-178.8M | $-179.8M | $1.0M | $13.5M |
| FY2025 | $-67.9M | $-67.9M | $0 | $12.5M |